ReutersJohnson & Johnson sues researchers who linked talc to cancerJul 13, 2023Dietrich KnauthBy Dietrich Knauthmore_vert
TheStreetJohnson & Johnson says it's finally making 'progress' on disturbing cancer lawsuitsDec 6Colin SalaoBy Colin Salaomore_vert
Mass DeviceJohnson & Johnson to submit surgical robot for FDA IDE next yearNov 7Sean WhooleyBy Sean Whooleymore_vert
Mesothelioma GuideBREAKING: Johnson & Johnson Bankruptcy Plan Rejected | Updated 2024Aug 3, 2023Devin GoldenBy Devin Goldenmore_vert
The New YorkerJohnson & Johnson and a New War on Consumer ProtectionSep 12, 2022Casey CepBy Casey Cepmore_vert
The New York TimesJohnson & Johnson Baby Powder at Issue as U.S. Subpoenas Company (Published 2019)Feb 21, 2019Tiffany HsuBy Tiffany Hsumore_vert
The GuardianJohnson & Johnson agrees to pay $8.9bn over alleged cancer-causing talc claimsApr 5, 2023more_vert
PR NewswireJohnson & Johnson Releases 2021 Health for Humanity Report Highlighting Performance on ESG Priorities and ...Jun 8, 2022more_vert
ForbesJohnson & Johnson Faces Another Crisis After Supreme Court DecisionJun 2, 2021Edward SegalBy Edward Segalmore_vert
DrugWatch.comJohnson & Johnson – Products, Recalls, Lawsuits & ScandalsApr 19, 2018Kristin ComptonBy Kristin Comptonmore_vert
CNNJohnson & Johnson is breaking up Band-Aids and pharmaceuticalsNov 12, 2021Jordan ValinskyBy Jordan Valinskymore_vert
The Wall Street JournalJohnson & Johnson Posts Higher Quarterly Sales, Raises 2023 OutlookApr 18, 2023Peter Loftus & Will FeuerBy Peter Loftus & Will Feuermore_vert
Bloomberg LawJohnson & Johnson Case Signals Employee Drug Price Suits to ComeFeb 9Sara HansardBy Sara Hansardmore_vert
Cardiovascular BusinessReport: Medtronic, Johnson & Johnson consider Shockwave Medical acquisition after Boston Scientific talks stallMay 11, 2023Michael WalterBy Michael Waltermore_vert
Johnson & JohnsonWhy Johnson & Johnson has made it a mission to improve surgical care in AfricaMay 21, 2017Michael H. UllmannBy Michael H. Ullmannmore_vert
ReutersJohnson & Johnson defends talc bankruptcy strategy called 'rotten' by cancer plaintiffsFeb 14, 2022Dietrich KnauthBy Dietrich Knauthmore_vert
Johnson & JohnsonThe Story Behind Johnson & Johnson's Historic Spring Cleaning AdsMar 29, 2017Liz KriegerBy Liz Kriegermore_vert
ReutersJ&J knew for decades that asbestos lurked in its Baby PowderDec 14, 2018Lisa GirionBy Lisa Girionmore_vert
The New York TimesJohnson & Johnson Investors Reject Move to End Global Sales of Talc Baby PowderApr 28, 2022Tiffany HsuBy Tiffany Hsumore_vert
ForbesJohnson & Johnson Faces Yet Another Crisis Situation This YearDec 17, 2021Edward SegalBy Edward Segalmore_vert
The New York TimesJohnson & Johnson Will Discontinue Talc-Based Baby Powder Globally in 2023 (Published 2022)Aug 11, 2022Roni Caryn Rabin & Tiffany HsuBy Roni Caryn Rabin & Tiffany Hsumore_vert
Johnson & JohnsonHow the microbiome could transform your skin in surprising waysJul 9, 2017Magdalena PuniewskaBy Magdalena Puniewskamore_vert
Cardiovascular BusinessReport: Johnson & Johnson once again considering deal to acquire Shockwave MedicalMar 27Michael WalterBy Michael Waltermore_vert
CNN'Reassuring' data suggests Johnson & Johnson vaccine may still have a role to play against Covid-19Mar 20, 2022Deidre McPhillips & Jen ChristensenBy Deidre McPhillips & Jen Christensenmore_vert
American Medical AssociationWhat doctors wish patients knew about the Johnson & Johnson vaccineMar 26, 2021Sara BergBy Sara Bergmore_vert
The New York TimesJohnson & Johnson Ordered to Pay $572 Million in Landmark Opioid Trial (Published 2019)Aug 26, 2019Jan HoffmanBy Jan Hoffmanmore_vert
FiercePharmaJohnson & Johnson unloads eye drops line to acquisitive Bausch + Lomb as Brent Saunders' deal streak rolls onJul 6, 2023Angus LiuBy Angus Liumore_vert
ReutersCourt tosses $223.8 million verdict against J&J in talc cancer caseOct 3, 2023Brendan PiersonBy Brendan Piersonmore_vert
Cardiovascular BusinessJohnson & Johnson acquires medical device company behind new LAA technology for $400MNov 30Michael WalterBy Michael Waltermore_vert
IR MagazineJohnson & Johnson on managing financial reputation through market turmoilMay 31, 2023Jonathan MairsBy Jonathan Mairsmore_vert
Infosecurity MagazineIBM Reports Patient Data Breach at Johnson & Johnson SubsidiarySep 7, 2023James CokerBy James Cokermore_vert
Asbestos.comJohnson & Johnson: History and Talcum Powder LawsuitsJun 23, 2018Walter Pacheco & Michelle WhitmerBy Walter Pacheco & Michelle Whitmermore_vert
CNNJohnson & Johnson will stop selling talc-based baby powder around the world in 2023Aug 12, 2022Jordan ValinskyBy Jordan Valinskymore_vert
Yahoo FinanceThe 'lingering uncertainties' for Johnson & Johnson in talc legal fightJul 28, 2023Alexis KeenanBy Alexis Keenanmore_vert
The GuardianJohnson & Johnson must pay $18.8m to cancer patient in baby powder lawsuitJul 19, 2023more_vert
ForbesHow Johnson & Johnson Could Regain Public's Trust In Covid Vaccine CrisisApr 16, 2021Edward SegalBy Edward Segalmore_vert
HIPAA JournalIBM and Johnson & Johnson Health Care Systems Sued Over August 2023 Data BreachSep 27, 2023more_vert
The New York TimesJohnson & Johnson Recalls Baby Powder Over Asbestos Worry (Published 2019)Nov 19, 2019Roni Caryn Rabin & Tiffany HsuBy Roni Caryn Rabin & Tiffany Hsumore_vert
BloombergA Johnson & Johnson Worker Alleges Company Overpaid for DrugsFeb 5John Tozzi & Chris DolmetschBy John Tozzi & Chris Dolmetschmore_vert
The New York TimesJohnson & Johnson Feared Baby Powder's Possible Asbestos Link for Years (Published 2018)Dec 14, 2018Roni Caryn Rabin & Tiffany HsuBy Roni Caryn Rabin & Tiffany Hsumore_vert
The New York TimesJ.&J. Pauses Production of Its Covid Vaccine Despite Persistent Need (Published 2022)Feb 8, 2022Stephanie Nolen, Rebecca Robbins & Sharon LaFraniereBy Stephanie Nolen, Rebecca Robbins & Sharon LaFranieremore_vert
The New York TimesJ&J Vaccine and Blood Clots: A Risk, if It Exists, Is TinyAug 27, 2021Denise Grady & Carl ZimmerBy Denise Grady & Carl Zimmermore_vert
Barron'sJohnson & Johnson's Kenvue Stock Swap Is a Good Deal for InvestorsJul 24, 2023Andrew BaryBy Andrew Barymore_vert
The New York TimesF.D.A. Attaches Warning of Rare Nerve Syndrome to Johnson & Johnson Vaccine (Published 2021)Aug 25, 2021Sharon LaFraniere & Noah Mercer WeilandBy Sharon LaFraniere & Noah Mercer Weilandmore_vert
The Wall Street JournalJ&J Consumer-Health IPO Process to Kick Off Key Test for Moribund New-Issue Market - WSJApr 23, 2023Corrie Driebusch & Peter LoftusBy Corrie Driebusch & Peter Loftusmore_vert
The New York TimesDrug Distributors and J.&J. Reach $26 Billion Deal to End Opioid Lawsuits (Published 2021)Nov 11, 2021Jan HoffmanBy Jan Hoffmanmore_vert
The Indian ExpressExplained: Why has Johnson and Johnson decided to discontinue its talc-based baby powder?Aug 14, 2022Raghu MalhotraBy Raghu Malhotramore_vert
CNNJohnson & Johnson recalls baby powder due to asbestos concernsOct 18, 2019Jacqueline HowardBy Jacqueline Howardmore_vert
Workers Comp ForumJohnson & Johnson's Vaccine Supply Chain Pitfall: Where Was the Risk Management?Apr 2, 2021Courtney DucheneBy Courtney Duchenemore_vert
The GuardianJohnson & Johnson to stop making talc-based baby powder globallyAug 12, 2022Mark SweneyBy Mark Sweneymore_vert
ABA Journal'The gloves are off': Baby powder maker J&J sues doctors who linked talc products to cancerJul 14, 2023Debra Cassens WeissBy Debra Cassens Weissmore_vert
Chicago TribuneTragedy, then triumph: How Johnson & Johnson made sure Tylenol survived the Tylenol murdersOct 27, 2022Christy Gutowski & Stacy St. ClairBy Christy Gutowski & Stacy St. Clairmore_vert
HBR.org DailyHow Johnson & Johnson and American Express Are Developing Young LeadersJun 8, 2018more_vert
The HinduIndia rejects Johnson & Johnson’s attempt to extend monopoly on lifesaving TB drugMar 24, 2023Maitri PorechaBy Maitri Porechamore_vert
Knowledge@WhartonLeadership Challenges at Johnson & Johnson - Knowledge at WhartonJan 9, 2014more_vert
Transport TopicsFedEx to Run Memphis Johnson & Johnson Distribution CenterFeb 10, 2016Wayne RisherBy Wayne Rishermore_vert
Fierce BiotechJohnson & Johnson CAR-T partner GenScript yo-yos on fake data allegationsSep 28, 2018more_vert
Knowledge@WhartonPatients versus Profits at Johnson & Johnson: Has the Company Lost its Way?Feb 15, 2012more_vert
The New York TimesWill Johnson & Johnson Recalls Change the Firm’s Reputation?Jan 15, 2011Reed Abelson & Natasha SingerBy Reed Abelson & Natasha Singermore_vert
Taiwan Business TOPICSJohnson & Johnson Is Making Room for Innovative Ideas to Thrive - Taiwan Business TOPICSOct 18, 2021more_vert
Taiwan Business TOPICSMeet Louis Ko of Johnson & Johnson - Taiwan Business TOPICSDec 16, 2020Jeremy OlivierBy Jeremy Oliviermore_vert
Taiwan Business TOPICSMeet Serena Chow of Johnson & Johnson - Taiwan Business TOPICSDec 15, 2021Jeremy OlivierBy Jeremy Oliviermore_vert
PBS NewsHourHow the Tylenol murders of 1982 changed the way we consume medicationSep 29, 2014Howard MarkelBy Howard Markelmore_vert
edie.netJohnson and Johnson faces up to supply chain challengeJun 23, 2014Edie NewsroomBy Edie Newsroommore_vert
Town TopicsJohnson & Johnson Heiress, Art Collector Barbara Piasecka Johnson RememberedApr 17, 2013more_vert